Sputum in severe exacerbations of asthma: Kinetics of inflammatory indices after prednisone treatment

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 5, 1997, Pages 1501-1508

  Pizzichini, Marcia M M ^a   Pizzichini, Emilio ^a   Clelland, Lynda ^a   Efthimiadis, Ann ^a   Mahony, James ^a   Dolovich, Jerry ^a   Hargreave, Frederick E ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; INTERLEUKIN 5; PREDNISONE; SALBUTAMOL; TERBUTALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CELL VIABILITY; CLINICAL ARTICLE; DOSE RESPONSE; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SLEEP DISORDER; SPUTUM ANALYSIS;

EID: 0030949914     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.5.9154849     Document Type: Article

References (36)

1. Laitinen, L. A., M. Heino, A. Laitinen, T. Hava, and T. Haahtela. 1985. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am. Rev. Respir. Dis. 131:599-606.
2. Beasley, R., R. R. Roche, J. A. Robertson, and S. T. Holgate. 1989. Cellular events in the bronchi in mild asthma before and after bronchoprovocation. Am. Rev. Respir. Dis. 139:808-817.
3. Gibson, P. G., A. Girgis-Gabardo, M. M. Morris, J. Dolovich, and F. E. Hargreave. 1989. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 44:693-699.
4. Pin, I., P. G. Gibson, R. Kolendowicz, J. A. Denburg, F. E. Hargreave, and J. Dolovich. 1992. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47:25-29.
5. Pizzichini, E., M. M. M. Pizzichini, A. Efthimiadis, S. Evans, M. M. Morris, D. Squillace, G. J. Gleich, J. Dolovich, and F. E. Hargreave. 1996. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid phase measurements. Am. J. Respir. Crit. Care Med. 154:808-817.
6. Ulrik, C. S. 1995. Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma. Clin. Exp. Allergy 25:820-827.
7. Pizzichini, E., M. M. M. Pizzichini, A. Efthimiadis, J. Dolovich, and F. E. Hargreave. 1997. Measuring airway inflammation in asthma: eosinophils and ECP in induced sputum compared with peripheral blood. J. Allergy Clin. Immunol. (In press.)
8. Lowell, F. C. 1967. Clinical aspects of eosinophilia in atopic diseases. J.A.M.A. 202:109-112.
9. Dunnill, M. S. 1960. The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13:27-33.
10. Azzavi, M., P. W. Johnston, S. Majundar, A. B. Kay, and P. K. Jeffery. 1992. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am. Rev. Respir. Dis. 145:1477-1482.
11. Sunjiv, S., T. B. Crotty, G. M. Kephart, B. A. Hyma, T. V. Colby, C. E. Reed, L. W. Hunt, and G. J. Gleich. 1993. Sudden onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa. Am. Rev. Respir. Dis. 148:713-719.
12. Baigelman, W., S. Chodosh, D. Pizzuto, and L. A. Cupples. 1983. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma. Am. J. Med. 75:929-936.
13. Corrigan, C. J., A. Hartnell, and A. B. Kay. 1988. T-lymphocyte activation in acute severe asthma. Lancet i:1129-1131.
14. Corrigan, C. J., and A. B. Kay. 1990. CD-4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am. Rev. Respir. Dis. 141:970-977.
15. Popov, T. A., M. M. M. Pizzichini, E. Pizzichini, R. Kolendowicz, Z. Punthakee, J. Dolovich, and F. E. Hargreave. 1995. Some technical factors influencing the induction of sputum for cell analysis. Eur. Respir. J. 8:559-565.
16. Killian, K. J., E. Summers, R. M. Watson, P. O'Byrne, N. L. Jones, and E. J. M. Campbell. 1993. Factors contributing to dyspnoea during bronchoprovocation and exercise in asthmatic subjects. Eur. Respir. J. 6:1004-1010.
17. American Thoracic Society. 1987. Standardization of spirometry: 1987 update. Am. Rev. Respir. Dis. 136:1285-1298.
18. Juniper, E. F., D. W. Cockcroft, and F. E. Hargreave. 1994. Histamine and methacholine inhalation tests: a laboratory tidal breathing protocol, 2nd ed. Astra Draco AB, Lund, Sweden.
19. Pepys, J. 1975. Skin test in diagnosis. In P. G. H. Gell, R. R. A. Coombs, and P. J. Lachmann, editors. Clinical Aspects of Immunology, 3rd ed. Blackwell Scientific Publications, Oxford. 55-80.
20. Pizzichini, E., M. M. M. Pizzichini, A. Efthimiadis, F. E. Hargreave, and J. Dolovich. 1996. Measurement of inflammatory indices in induced sputum: effects of selection of the sputum to minimize salivary contamination. Eur. Respir. J. 9:1174-1180.
21. Glantz, S. A. and B. K. Slinker. 1990. Repeated measures. In S. A. Glantz and B. K. Slinker, editors. Primer of Applied Regression and Analysis of Variance. McGraw-Hill, Inc. Health Professions Division, New York. 381-420.
22. Filley, W. V., G. M. Kephart, K. E. Holley, and G. J. Gleich. 1982. Identification by immunofluorescence of eosinophil granule major basic protein in lung of patients with bronchial asthma. Lancet 2:11-15.
23. Horwitz, R. I., C. M. Viscoli, J. D. Clemens, and R. T. Sadok. 1990. Developing improved observational methods for evaluating therapeutic effectiveness. Am. J. Med. 89:630-638.
24. Popov, T., R. Gottschalk, R. Kolendowicz, J. Dolovich, P. Powers, and F. E. Hargreave. 1994. The evaluation of a cell dispersion method of sputum examination. Clin. Exp. Allergy 24:778-783.
25. Efthimiadis, A., M. M. M. Pizzichini, S. Weston, E. Pizzichini, S. Evans, J. Dolovich, and F. E. Hargreave. 1996. Sputum cellular and fluid phase components: comparison of the effect of dithiothreitol vs phosphate buffered saline (abstract). J. Allergy Clin. Immunol. 97:A513.
26. Pizzichini, M. M. M., T. Popov, A. Efthimiadis, P. Hussack, S. Evans, E. Pizzichini, J. Dolovich, and F. E. Hargreave. 1996. Spontaneous and induced sputum to measure indices of airway inflammation. Am. J. Respir. Crit. Care. Med. 154:866-869.
27. Messina, M. S., T. G. O'Riordan, and G. C. Smaldone. 1991. Changes in mucociliary clearance during acute exacerbations of asthma. Am. Rev. Respir. Dis. 143:993-997.
28. Frigas, E., D. A. Loegering, G. O. Graham, G. M. Farrow, and G. J. Gleich. 1981. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin. Proc. 56:345-353.
29. Kips, J. C., P. H. Rytilä, R. A. Peleman, G. F. Joos, and R. A. Pauwels. 1995. Evaluation of within subject variability in sputum cell counts (abstract). Am. J. Respir. Crit. Care Med. 151:A386.
30. Jarjour, N. N., and W. J. Calhoun. 1990. Bronchoalveolar lavage in stable asthmatics does not cause pulmonary inflammation. Am. Rev. Respir. Dis. 142:100-103.
31. Fahy, J. V., K. W. Kim, J. Liu, and H. A. Boushey. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 95:843-852.
32. Turner, M. O., P. Hussack, M. R. Sears, J. Dolovich, and F. E. Hargreave. 1995. Exacerbations of asthma without sputum eosinophilia. Thorax 50:1057-1061.
33. Haskell, R. J., B. M. Wong, and J. E. Hansen. 1983. A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus. Arch. Intern. Med. 143:1324-1327.
34. Barnes, P. J., and I. M. Adcock. 1995. Steroid resistance in asthma. Q. J. Med. 88:455-458.
35. Bentley, A. M., Q. Hamid, D. S. Robinson, E. Schotman, Q. Meng, B. Assoufi, A. B. Kay, and S. R. Durham. 1996. Prednisolone treatment in asthma: reduction in the number of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma gene expression within the bronchial mucosa. Am. J. Respir. Crit. Care Med. 153:551-556.
36. Boschetto, P., D. F. Rogers, L. M. Fabri, and P. J. Barnes. 1991. Corticosteroid inhibition of airway microvascular leakage. Am. Rev. Respir. Dis. 143:605-609.